OptumInsight, Inc. announced earnings results for the third quarter and nine months ended September 30, 2012. For the quarter, revenues were $0.718 billion against $0.625 billion for the same period a year ago. Earnings from operations were $0.126 billion against $0.91 billion for the same period a year ago. For the nine months, revenues were $2.060 billion against $1.954 billion for the same period a year ago. Earnings from operations were $0.310 billion against $0.261 billion for the same period a year ago.

Unitedhealth Group, Inc. and OptumInsight, Inc. on September 6, 2012, when the US District Court for the Central District of California dismissed all claims brought against them in the a multidistrict litigation entitled In re WellPoint, Inc. The In re WellPoint plaintiffs (putative classes of WellPoint health plan members and their providers, as well as several medical associations) alleged that WellPoint engaged in a conspiracy with UHG, Ingenix, and others to control the market for charges data upon which managed care companies allegedly based their out-of-network (OON) reimbursements, and then used that control to enable Ingenix to produce a flawed charges database that WellPoint and others employed to underpay OON claims. The plaintiffs asserted claims against UHG and Ingenix under the Sherman Act, RICO and California's Cartwright Act. In his 52-page decision, US District Judge dismissed all claims against UHG and Ingenix. The court agreed with Weil's argument that the provider-plaintiffs and association-plaintiffs did not adequately allege an injury recoverable under the Sherman Act, RICO or the Cartwright Act, and dismissed their claims with prejudice. Further, the court held that the health plan member-plaintiffs failed to connect their alleged injury being under-reimbursed for OON services to the defendants alleged exclusion of competitors from the charges data market, and accordingly dismissed their Sherman Act and Cartwright Act claims. Turning to the health plan member-plaintiffs RICO claims, the court agreed with Weil's argument that the plaintiffs failed to plead reliance on any alleged misrepresentation, as well as failed adequately to plead any predicate acts by UHG. The court set a deadline of November 1st for the health plan member-plaintiffs to try to re-plead some of their claims.

OPTUMInsight Life Sciences Presents at 2012 BIO International Convention, Jun-18-2012 . Venue: Beston Convention & Exhition Center, Boston, Massachusetts, United States. Speakers: William Crown, President, HEOR and Late Phase Research.